We are live on ! Find out more
AC

AlphaCore Capital Portfolio holdings

AUM $4.22B
1-Year Est. Return 21.28%
This Fund
S&P 500
This Quarter Est. Return
+0.49%
1 Year Est. Return
+21.28%
3 Year Est. Return
+68.34%
5 Year Est. Return
+65.67%
10 Year Est. Return
–
AUM
$4.22B
AUM Growth
-$265M
Cap. Flow
-$258M
Cap. Flow %
-6.12%
Top 10 Hldgs %
23.34%
Holding
1,540
New
118
Increased
332
Reduced
581
Closed
339

Top Buys

Rank Stock Value
1
VV icon
Vanguard Large-Cap ETF
VV
+$51.1M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$14.6M
3
VTV icon
Vanguard Value ETF
VTV
+$13.9M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$13.4M
5
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$10.7M

Top Sells

Rank Stock Value
1
IBRX icon
ImmunityBio
IBRX
+$20.4M
2
IYF icon
iShares US Financials ETF
IYF
+$17M
3
IYC icon
iShares US Consumer Discretionary ETF
IYC
+$16.8M
4
VUG icon
Vanguard Growth ETF
VUG
+$16.4M
5
CDTX
Cidara Therapeutics
CDTX
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 6.67%
2 Energy 4.51%
3 Communication Services 3.81%
4 Financials 3.41%
5 Healthcare 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALAB icon
726
Astera Labs
ALAB
$52B
$271K 0.01%
+2,474
New +$352K
LVS icon
727
Las Vegas Sands
LVS
$30.1B
$270K 0.01%
5,016
+1,685
+51% +$95.9K
LYV icon
728
Live Nation Entertainment
LYV
$41.9B
$270K 0.01%
+1,771
New +$268K
NVG icon
729
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.73B
$270K 0.01%
21,737
+260
+1% +$3.34K
NTNX icon
730
Nutanix
NTNX
$14.9B
$268K 0.01%
7,062
+3,009
+74% +$127K
IHE icon
731
iShares US Pharmaceuticals ETF
IHE
$1.27B
$268K 0.01%
3,090
– –
TOL icon
732
Toll Brothers
TOL
$14.1B
$268K 0.01%
1,961
+366
+23% +$53.7K
CBNA
733
Chain Bridge Bancorp
CBNA
$275M
$267K 0.01%
7,651
+1
+0% +$35
IUSG icon
734
iShares Core S&P US Growth ETF
IUSG
$31.4B
$267K 0.01%
1,721
+40
+2% +$6.58K
FAST icon
735
Fastenal
FAST
$52.2B
$267K 0.01%
5,750
-2,405
-29% -$108K
ENZL icon
736
iShares MSCI New Zealand ETF
ENZL
$68.1M
$267K 0.01%
6,250
– –
BEN icon
737
Franklin Resources
BEN
$17B
$266K 0.01%
11,220
+4,392
+64% +$113K
RIVN icon
738
Rivian
RIVN
$25.3B
$265K 0.01%
+17,638
New +$282K
TECH icon
739
Bio-Techne
TECH
$11.2B
$265K 0.01%
+5,076
New +$305K
CDW icon
740
CDW
CDW
$17B
$265K 0.01%
2,189
+376
+21% +$47.5K
PHYS icon
741
Sprott Physical Gold
PHYS
$14.4B
$264K 0.01%
7,442
-120,295
-94% -$4.45M
PPL
742
PPL Corp
PPL
$27B
$261K 0.01%
6,793
-17,102
-72% -$631K
IVLU icon
743
iShares MSCI Intl Value Factor ETF
IVLU
$4.28B
$260K 0.01%
6,565
– –
SSNC icon
744
SS&C Technologies
SSNC
$16.8B
$260K 0.01%
3,846
-661
-15% -$50.8K
ACNB icon
745
ACNB Corp
ACNB
$617M
$259K 0.01%
5,416
-998
-16% -$49.2K
ESEA icon
746
Euroseas
ESEA
$488M
$259K 0.01%
+3,877
New +$233K
AXS icon
747
AXIS Capital
AXS
$8.46B
$258K 0.01%
2,531
-502
-17% -$51.5K
G icon
748
Genpact
G
$5.24B
$256K 0.01%
6,883
-4,751
-41% -$196K
AVY icon
749
Avery Dennison
AVY
$12.3B
$255K 0.01%
+1,479
New +$272K
IHF icon
750
iShares US Healthcare Providers ETF
IHF
$1.19B
$255K 0.01%
6,099
– –
28 29
30
31 32

Similar funds

DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return

AlphaCore Capital's Q1 2026 Portfolio in Review

As of Q1 2026, AlphaCore Capital held 1,540 positions worth $4.22B, down 5.9% from $4.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

AlphaCore Capital withdrew a net $258M in Q1 2026, closing 339 positions and reducing 581 holdings. Its most notable exit was Cidara Therapeutics, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.7% of assets, down from 7.5% a quarter earlier, followed by Energy and Communication Services.

Against the trend, AlphaCore Capital opened a new position in American Beacon GLG Natural Resources ETF worth $5.59M.

  • AlphaCore Capital's largest Q1 2026 buy was American Beacon GLG Natural Resources ETF: 108,404 shares worth $5.59M.
  • AlphaCore Capital added most to Vanguard Large-Cap ETF in Q1 2026, an estimated $51.1M increase.
  • AlphaCore Capital's biggest Q1 2026 reduction was ImmunityBio, cutting an estimated $20.4M.
  • AlphaCore Capital fully exited Cidara Therapeutics in Q1 2026, selling an estimated $14.8M.
  • AlphaCore Capital's ten largest holdings make up 23% of its $4.22B portfolio in Q1 2026.
  • AlphaCore Capital opened 118 new positions and closed 339 in Q1 2026.
  • AlphaCore Capital's portfolio value fell 5.9% quarter-over-quarter to $4.22B.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.